SUBLINOX
Identification of Sublinox
| No description |
Google image searchProduct monograph
Active ingredient
zolpidem tartrate, 5 MG
DIN: 02391678
Dosage form(s): TABLET (ORALLY DISINTEGRATING)
Route(s) of administration: SUBLINGUAL
Schedule: Targeted (CDSA IV)
Company: BAUSCH HEALTH, CANADA INC.
Date: 05-JUL-2019
ATC:
- N05 — PSYCHOLEPTICS (ATC, ATC/DDD, )
- N05C — HYPNOTICS AND SEDATIVES (ATC, ATC/DDD)
- N05CF — Benzodiazepine related drugs (ATC, ATC/DDD)
- N05CF02 — ZOLPIDEM (ATC/DDD)
Reference brand drug: Sublinox
